NCT06429787
- Conditions
- Significant Bleeding Risk, Vitamin K-Dependent Clotting Factors, Combined Deficiency Of, 1, Vitamin K-Dependent Coagulation Defect
- Locations
-
- Octapharma Research Site Boston, Massachusetts, United States
Clinical trial condition
Significant Bleeding Risk
Explore clinical trials studying Significant Bleeding Risk. Study availability and eligibility vary by location and protocol.
2 public trials
1 recruiting study
Significant Bleeding Risk trial results
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
- Locations
-
- Octapharma Research Site Aurora, Colorado, United States
- Octapharma Research Site New Haven, Connecticut, United States
- Octapharma Research Site Miami, Florida, United States
- Octapharma Research Site Tampa, Florida, United States